Who owns WEREWOLF THERAPEUTICS INC?
- Ticker: HOWL
- CUSIP Number: 95075a107
Tip: Access positions for across all investors
Analyze quarterly positions in Werewolf Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Werewolf Therapeutics stock
Who bought or sold WEREWOLF THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 2.4M | $859k | -64% | Jun 2026 |
|
| Balyasny Asset Management | 1.8M | $644k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 1.2M | $439k | 0% | Jun 2026 |
|
| Renaissance Technologies | 675k | $243k | 31% | Jun 2026 |
|
| Lynx1 Capital Management | 658k | $237k | 0% | Jun 2026 |
|
| Sphera Funds Management | 627k | $226k | 0% | Jun 2026 |
|
| DC Funds | 589k | $212M | 0% | Jun 2026 |
|
| Verdad Advisers | 349k | $126k | 1072% | Jun 2026 |
|
| Geode Capital Management | 336k | $121k | -14% | Jun 2026 |
|
| Bank of America Corporation | 312k | $112k | 18% | Jun 2026 |
|
| XTX Topco | 272k | $98k | 433% | Jun 2026 |
|
| Jane Street | 252k | $91k | 204% | Jun 2026 |
|
| UBS Group | 216k | $78k | 223% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 158k | $57k | 0% | Jun 2026 |
|
| State Street Corporation | 119k | $99k | 0% | Mar 2026 |
|
| Squarepoint Ops | 103k | $37k | 100% | Jun 2026 |
|
| BlackRock | 102k | $37k | 0% | Jun 2026 |
|
| Rangeley Capital | 100k | $36k | 100% | Jun 2026 |
|
| Citadel Advisors | 91k | $33k | 772% | Jun 2026 |
|
| Northern Trust | 87k | $31k | 0% | Jun 2026 |
|
| Alyeska Investment Group | 87k | $31k | 0% | Jun 2026 |
|
| MPM Oncology Impact Management | 80k | $29k | -93% | Jun 2026 |
|
| Millennium Management | 62k | $22k | -53% | Jun 2026 |
|
| Virtu Financial | 46k | $16k | 100% | Jun 2026 |
|
| Morgan Stanley | 34k | $28k | -27% | Mar 2026 |
|
| Two Sigma Investments | 27k | $9.8k | 100% | Jun 2026 |
|
| GSA Capital Partners | 27k | $10k | 100% | Jun 2026 |
|
| Goldman Sachs Group | 20k | $7.2k | -48% | Jun 2026 |
|
| Intl Fcstone | 20k | $9.0k | 100% | Jun 2026 |
|
| Camden Capital | 15k | $5.4k | 0% | Jun 2026 |
|
| Barclays | 13k | $4.8k | 0% | Jun 2026 |
|
| HBK Sorce Advisory | 13k | $5.3k | 0% | Jun 2026 |
|
| Larson Financial Group | 13k | $4.7k | 0% | Jun 2026 |
|
| LPL Financial | 12k | $4.2k | 18% | Jun 2026 |
|
| Pacitti Group | 11k | $4.0k | -8% | Jun 2026 |
|
| Marest Capital | 11k | $3.9k | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 10k | $3.7k | 0% | Jun 2026 |
|
| Tower Research Capital | 9.9k | $3.6k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 8.6k | $3.1k | 0% | Jun 2026 |
|
| Financial Perspectives | 6.8k | $2.4k | 0% | Jun 2026 |
|
| Citigroup | 3.4k | $2.8k | 100% | Mar 2026 |
|
| Jpmorgan Chase & Co | 2.1k | $649.896400 | 100% | Jun 2026 |
|
| Group One Trading | 1.9k | $672.998700 | 0% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 790.00 | $284.005000 | 0% | Jun 2026 |
|
| Simplex Trading | 255.00 | $91.009500 | -99% | Jun 2026 |
|
| SBI Securities | 100.00 | $36.000000 | 25% | Jun 2026 |
|
| Optiver Holding B.V. | 22.00 | $7.999200 | 0% | Jun 2026 |
|
Who sold out of Werewolf Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Squadron Capital Management | Mar 2026 | 564k | $469k |
| Bridgeway Capital Management | Mar 2026 | 77k | $64k |
| Raymond James Financial | Mar 2026 | 20k | $17k |
| Hrt Financial | Mar 2026 | 18k | $14k |
| Delta Investment Management | Mar 2026 | 15k | $12k |
| Vanguard Global Advisers | Mar 2026 | 10k | $8.6k |
| TFC Financial Management | Mar 2026 | 4.5k | $3.7k |
| Northwestern Mutual Wealth Management Company | Mar 2026 | 200.00 | $167.000000 |
| FMR | Mar 2026 | 39.00 | $31.999500 |